Top Markets
#1 ADO Protocol ADO Protocol +193.85%
#2 GoPlus Security GoPlus Security +36.55%
#3 GAIB AID GAIB AID +24.67%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.22%
#5 Tutorial Tutorial +16.90%
#6 SkyAI SkyAI +16.67%
#7 Pons Pons +13.86%
#8 Verus Coin Verus Coin +13.11%
#9 Status Status +12.83%
#10 o1.exchange o1.exchange +12.80%
Coin of the day
ADO Protocol ADO Protocol
設定
言語
日本
通貨
USD
テーマ
Vectus Biosystems Limited Vectus Biosystems Limited

Vectus Biosystems Limited

VBS
株式のランク #33546
Vectus Biosystems Limited, an Australian medical research and development firm,... Vectus Biosystems Limited, an Australian medical research and development firm, specializes in devising therapies for fibrotic conditions and hypertension. Its pharmaceutical pipeline addresses ailments affecting the heart, kidneys, liver, and lungs. The company's leading experimental drug, VB0004, aims to counter the degradation of functional tissue resulting from fibrosis, scarring, and elevated blood pressure. Furthermore, Vectus intends to advance treatments for hepatic fibrotic diseases, such as non-alcoholic steatohepatitis, and various pulmonary fibrotic disorders. Beyond its therapeutic endeavors, the company also provides AccuCal and RealCount software, tools engineered to enhance the swiftness and precision of DNA and RNA quantification in laboratory settings. Established in 2005, Vectus Biosystems is headquartered in Rosebery, Australia.
株価
$0.11989842
時価総額
$7.42M
変化（1日）
6.25%
変化（1年）
179.27%
国
AU
取引 Vectus Biosystems Limited (VBS)

カテゴリー

Healthcare
Vectus Biosystems Limited（VBS）の株式分割履歴
Vectus Biosystems Limited株（シンボル：VBS）は合計で0回の株式分割を実施しました。
最新の株式分割はAug 17, 2026に行われました。
Aug 17, 2026より前に購入されたVBS株は、現在0VBS株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE